Germline mutations in HOXB13 and prostate-cancer risk

New England Journal of Medicine

Volumn 366, Issue 2, 2012, Pages 141-149

  Ewing, Charles M ^a   Ray, Anna M ^b   Lange, Ethan M ^c   Zuhlke, Kimberly A ^b   Robbins, Christiane M ^e   Tembe, Waibhav D ^e   Wiley, Kathleen E ^a   Isaacs, Sarah D ^a   Johng, Dorhyun ^a   Wang, Yunfei ^c   Bizon, Chris ^d   Yan, Guifang ^a   Gielzak, Marta ^a   Partin, Alan W ^a   Shanmugam, Vijayalakshmi ^e   Izatt, Tyler ^e   Sinari, Shripad ^e   Craig, David W ^e   Zheng, S Lilly ^f   Walsh, Patrick C ^a   Montie, James E ^b   Xu, Jianfeng ^f   Carpten, John D ^e   Isaacs, William B ^a   Cooney, Kathleen A ^b   more..

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d Renaissance Computing Institute   (United States)

^e TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CYSTEINE; GLUTAMIC ACID; GLYCINE; GUANINE; HOMEODOMAIN PROTEIN; HOXB13 PROTEIN, HUMAN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 17Q; CHROMOSOME 17Q21-22; CONTROLLED STUDY; DNA SEQUENCE; EARLY CANCER; FAMILIAL CANCER; FAMILY HISTORY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HOMEOBOX; HOXB13 GENE; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; CHROMOSOME 17; GENETICS; HIGH THROUGHPUT SEQUENCING; MIDDLE AGED; MUTATION; PATHOLOGY; PEDIGREE; PROSTATE; PROSTATE TUMOR;

CHROMOSOMES, HUMAN, PAIR 17; GENETIC LINKAGE; GERM-LINE MUTATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PROSTATE; PROSTATIC NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 84856176782     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1110000     Document Type: Article

References (35)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-36.
2. Langeberg WJ, Isaacs WB, Stanford JL. Genetic etiology of hereditary prostate cancer. Front Biosci 2007;12:4101-10.
3. Kim ST, Cheng Y, Hsu FC, et al. Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic variation. Prostate 2010;70: 1729-38.
4. Kote-Jarai Z, Olama AA, Giles GG, et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet 2011;43:785- 91.
5. Lange EM, Gillanders EM, Davis CC, et al. Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan Prostate Cancer Genetics Project finds evidence for linkage on chromosome 17 near BRCA1. Prostate 2003;57:326-34. (Pubitemid 37487078)
6. Gillanders EM, Xu J, Chang BL, et al. Combined genome-wide scan for prostate cancer susceptibility genes. J Natl Cancer Inst 2004;96:1240-7. (Pubitemid 39232715)
7. Xu J, Dimitrov L, Chang BL, et al. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the International Consortium for Prostate Cancer Genetics. Am J Hum Genet 2005;77:219- 29.
8. Lange EM, Robbins CM, Gillanders EM, et al. Fine-mapping the putative chromosome 17q21-22 prostate cancer susceptibility gene to a 10 cM region based on linkage analysis. Hum Genet 2007;121:49- 55.
9. Exome variant server. Seattle: NHLBI Exome Sequencing Project (http://snp.gs .washington.edu/EVS).
10. The International HapMap Consortium. A haplotype map of the human genome. Nature 2005;437:1299-320.
11. 1000 Genomes: a deep catalog of human variation (http://www.1000genomes .org/home).
12. Lange EM, Salinas CA, Zuhlke KA, et al. Early onset prostate cancer has a significant genetic component. Prostate 2011 May 2 (Epub ahead of print).
13. Lange EM, Beebe-Dimmer JL, Ray AM, et al. Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23. Prostate 2009;69:385-91.
14. Xu J, Zheng SL, Komiya A, et al. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet 2002;32:321-5.
15. Zheng SL, Sun J, Cheng Y, et al. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J Natl Cancer Inst 2007;99: 1525-33. (Pubitemid 351767236)
16. Liu W, Xie CC, Zhu Y, et al. Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer. Neoplasia 2008;10:897- 907.
17. Ng PC, Henikoff S. Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet 2006;7:61-80. (Pubitemid 44627922)
18. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 2002;30:3894- 900.
19. Williams TM, Williams ME, Innis JW. Range of HOX/TALE superclass associations and protein domain requirements for HOXA13:MEIS interaction. Dev Biol 2005;277:457-71. (Pubitemid 40022964)
20. Haiman CA, Chen GK, Blot WJ, et al. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet 2011;43:570-3.
21. Gudmundsson J, Sulem P, Steinthorsdottir V, et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 2007;39:977-83. (Pubitemid 47185170)
22. Graham A. Developmental patterning: the Hox code out on a limb. Curr Biol 1994;4:1135-7. (Pubitemid 124001604)
23. Goodman FR, Scambler PJ. Human HOX gene mutations. Clin Genet 2001;59: 1-11. (Pubitemid 32049120)
24. Economides KD, Zeltser L, Capecchi MR. Hoxb13 mutations cause overgrowth of caudal spinal cord and tail vertebrae. Dev Biol 2003;256:317-30. (Pubitemid 36390101)
25. Economides KD, Capecchi MR. Hoxb13 is required for normal differentiation and secretory function of the ventral prostate. Development 2003;130:2061-9. (Pubitemid 36656703)
26. Thorsteinsdottir U, Kroon E, Jerome L, Blasi F, Sauvageau G. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia. Mol Cell Biol 2001;21:224-34.
27. Jung C, Kim RS, Zhang HJ, Lee SJ, Jeng MH. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling. Cancer Res 2004;64: 9185-92. (Pubitemid 39665535)
28. Norris JD, Chang CY, Wittmann BM, et al. The homeodomain protein HOXB13 regulates the cellular response to androgens. Mol Cell 2009;36:405-16.
29. Kim JH, Dhanasekaran SM, Mehra R, et al. Integrative analysis of genomic aberrations associated with prostate cancer progression. Cancer Res 2007;67:8229-39. (Pubitemid 47395160)
30. Fukasawa S, Kino M, Kobayashi M, et al. Genetic changes in pT2 and pT3 prostate cancer detected by comparative genomic hybridization. Prostate Cancer Prostatic Dis 2008;11:303-10.
31. Edwards S, Campbell C, Flohr P, et al. Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. Br J Cancer 2005;92:376- 81.
32. Thompson D, Easton DF. Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002;94:1358-65. (Pubitemid 35154140)
33. Ostrander EA, Udler MS. The role of the BRCA2 gene in susceptibility to prostate cancer revisited. Cancer Epidemiol Biomarkers Prev 2008;17:1843-8.
34. Schehl-Sinclair C, Berry R, Schaid D, Thibodeau SN, Couch FJ. BRCA1 and BRCA2 have a limited role in familial prostate cancer. Cancer Res 2000;60:1371-5. (Pubitemid 30152009)
35. Zuhlke KA, Madeoy JJ, Beebe-Dimmer J, et al. Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers. Clin Cancer Res 2004;10:5975-80. (Pubitemid 39287501)